Curtiss Moore
Clinical Cardiac Electrophysiology · Mansfield, TXNPI 1184950503
Payments from drug & device makers
Across 391 payments — averaging $33.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Medtronic$2K
- Boston Scientific$1K
- Johnson & Johnson$395
- Biosense Webster, Inc.$348
- Biotronik Inc.$328
- plus $2K from 28 others
What the payments were for
- Travel & lodging$1,96615%
- Food & beverage$11,08085%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 187 | $7,120 |
| Medtronic(2 entities) | 50 | $1,767 |
| Boston Scientific | 13 | $1,027 |
| Johnson & Johnson(2 entities) | 25 | $395 |
| Biosense Webster, Inc. | 5 | $348 |
| Biotronik Inc. | 9 | $328 |
| E.r. Squibb & Sons, L.L.C. | 17 | $295 |
| Cordis US CORP. | 3 | $278 |
| Merck | 12 | $199 |
| Pfizer | 10 | $178 |
| AstraZeneca | 4 | $171 |
| Novartis | 10 | $169 |
| Sanofi-aventis U.S. LLC | 10 | $163 |
| Amgen | 6 | $110 |
| Cardiva Medical, Inc. | 3 | $59 |
| Edwards Lifesciences | 3 | $54 |
| Cardiovascular Systems Inc. | 2 | $52 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| Boehringer Ingelheim | 2 | $33 |
| Terumo Medical Corporation | 2 | $31 |
| Elutia, Inc. | 2 | $29 |
| Irhythm Technologies, Inc. | 1 | $25 |
| Atricure, Inc. | 1 | $17 |
| BD | 1 | $16 |
| Vital Connect, Inc | 1 | $16 |
| Cvrx, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Kestra Medical Technology Services, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Novo Nordisk | 1 | $14 |
| Philips North America LLC | 1 | $12 |
| Cook Medical LLC | 1 | $12 |
| Convatec Inc. | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$1,427
- ADVISOR$702
- GENERAL - THERAPIES$490
- Xience Sierra Coronary Stent System$449
- Carto 3$268
- ENSITE$263
- AURORA EV-ICD MRI SURESCAN$220
- Confirm Rx$188
- EVERA MRI XT DR SURESCAN$179
- AMPLATZER TALISMAN$172
- PulseSelect$162
- EnSite Precision Cardiac Mapping System$161
- XIENCE SIERRA$156
- LATITUDE Communicator Power Supply$139
- ENSITE PRECISION$137
- Edora$128
- BioMonitor$128
- Acticor$128
- Rivacor$128
- Solia$128
How this compares
$13,046 in reported general payments places this provider in the 20th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 311 | $365,820 |
| JardianceEmpagliflozin | 62 | $67,011 |
| XareltoRivaroxaban | 38 | $38,180 |
| MultaqDronedarone Hcl | 14 | $24,825 |
| Dofetilide | 51 | $14,296 |
| EntrestoSacubitril/Valsartan | 18 | $13,399 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 15 | $4,857 |
| Flecainide Acetate | 98 | $4,330 |
| Metoprolol Succinate | 214 | $3,208 |
| SotalolSotalol Hcl | 80 | $2,428 |
| Amiodarone Hcl | 142 | $1,721 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $751 |
| Carvedilol | 84 | $728 |
| Furosemide | 92 | $475 |
| ClopidogrelClopidogrel Bisulfate | 34 | $475 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $178 | $365,820311 claims |
| Boehringer IngelheimJardiance | $33 | $67,01162 claims |
| Johnson & JohnsonXarelto | $395 | $38,18038 claims |
| Sanofi-aventis U.S. LLCMultaq | $163 | $24,82514 claims |
| NovartisEntresto | $169 | $13,39918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Mansfield
- Andrea NataleAustin$7.8M
- George ManoukianShenandoah$3.2M
- Rodney HortonAustin$2.5M
- Stanislav WeinerLongview$2.4M
- Michael DelaughterBedford$2.1M
- James DevillePlano$1.5M
- Robert CanbyAustin$1.5M
- Amin Al-AhmadAustin$1.4M
- Theodore TakataFort Worth$1.4M
- Miguel ValderrabanoHouston$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.